BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders. With pathfinder™, our computational psychiatry platform, our approach is based on generating a quantitative, brain-based understanding of neurobehavioral disorders. These data-driven insights are applied to create treatments targeted to biologically-based subtypes of patients to increase the precision of therapeutic intervention. Our clinical pipeline is designed to restore balance to dysregulated brain circuits and empower individuals with CNS disorders to live better lives. BlackThorn is headquartered in San Francisco, California. For more information, please visit blackthornrx.com.
B2B
26 to 50
Series B
$138,000,000
Scaling Up
2015
Pharmaceuticals and Medical Products
Healthcare
Biotechnology
N/A
Healthcare
Analytics
Service
Yes
Active
Machine Learning
Machine Perception
Knowledge Representation and Reasoning
N/A
Software
N/A
N/A
Potential Customers
Interested in what they do or partnership?
Learn more about how they work